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Abstract 
Background 
The Renal Nutrition Group of the British Dietetic Association (BDA-RNG) developed three renal-
specific Dietetic Outcome Models and a Renal Dietetic Outcome Tool (RDOT) to measure dietetic 
outcomes in potassium and phosphate management and oral nutrition support in patients with 
Chronic Kidney Disease (CKD). 
Methods 
Participating renal units collected relevant outcome data using the RDOT for all newly referred 
outpatients with CKD stage 4 or 5 within a three month period excluding patients with a 
functioning kidney transplant. 
Findings  
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21 units collectively completed data on 742 patients. 87% achieved their outcome for potassium 
management, 66% for phosphate management and 58% for oral nutrition support (ONS). Patients 
seen two or more times by the renal dietitian demonstrated improved outcomes particularly those 
on haemodialysis (p=0.01). 
Conclusion 
The RDOT can be used to evaluate current renal dietetic services to assist with development of 
service provision and workforce planning as well as to compare renal dietetic services across the 
UK. 
Introduction 
Providers and commissioners of care require both cost and clinically effective services within the 
National Health Service (NHS). However, this is challenging for all disciplines within the multi-
professional team due to limited resources and increased demands, leading to lack of time for 
quality measurement.  
Since 2010 there have been three key publications directing dietitians to the importance of 
measuring clinical outcomes (DOH 2010, BDA 2011, HCPC 2013). In addition, the NHS Five-Year 
Forward View for England (NHS England 2014) outlines an on-going drive for improving the quality 
of care using the three main themes of patient experience, safety and effectiveness.   
In clinical practice, healthcare utilisation and cost outcomes as well as mortality and morbidity 
rates are often used to measure the impact of interventions (DOH 2016). As there are many 
healthcare professionals that contribute to the patient’s care plan to achieve these outcomes, the 
parameters used to show effectiveness can lead to blurred lines of accountability between 
medical, pharmacology, dietetic and nursing interventions. Enhanced understanding of the 
outcomes relating to dietetic interventions would lead to strengthening the value of evaluating 
and improving dietetic services provided.  
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In the UK, Allied Health Professionals use a variety of therapy tools, models and systems to 
determine the impact of their intervention, relating to their service type and client groups. 
Dietitians in the UK have utilised a variety of models including Therapy Outcome Measures 
(Enderby et al. 2015) and the Care aims approach (Malcomess and Wilson 2015). However, none 
of the therapy models have proved generally applicable, amenable, or transferable to the work of 
dietitians in the acute care setting where the emphasis is on nutritional status and nutritional 
intake.  
The identification and development of outcome measures for dietetics has been an on-going 
challenge for the profession. It is only in recent years that dietitians have started to develop and 
share tool kits for measuring dietetic outcomes in patients requiring nutrition support (Davies 
2016; PENG 2016).  
Where there is research into the impact of renal dietetic intervention on patient outcomes, it is 
often limited and low grade (Ash et al. 2014). Outcomes tend to focus on one biochemical end-
point (Sullivan et al. 2009; Reddy et al. 2009; Karavetian and Ghaddar 2013) or a measure of 
nutritional status (Stratton et al. 2005; Bellizzi et al. 2010). The studies fail to capture the context 
of the clinical setting, what facilitates or hinders change and how this impacts on patients’ 
outcome and experience. Only a few studies have shown the effectiveness of dietary intervention 
in practice (Campbell et al. 2009; Calderia et al. 2011).   
In 2011 a working group of the BDA-RNG was formed to develop guidance on identifying and 
capturing dietetic outcomes for renal dietitians in clinical practice.  Prior to starting this work, 
there were no UK validated, sensitive and reliable, dietetic outcome measures available for 
routine use in clinical practice (BDA 2011). Steiber et al (2015)  has since developed a nutrition 
algorithm which is a computerised aid to help clinical decisions as well as track dietetic outcomes 
in haemodialysis patients. 
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The RNG Dietetic Outcomes Pack developed by the working group can be accessed on 
(https://www.bda.uk.com/regionsgroups/groups/renal/outcometools) and consists of: 
• Three outcome models on potassium and phosphate management and ONS Although in 
clinical practice the renal dietitian may advise on a combination of dietary issues during 
one consultation, it was felt that collecting data relating to individual dietetic interventions 
would provide greater understanding of the impact of a dietetic intervention in CKD.  
Each model outlines the main outcome, timeframe and rationale of the intervention as well as a 
list of SMART goals to be identified and agreed with the patient at the start of the episode of care. 
Various markers and tools to measure changes in goals are suggested. 
• A list of barriers – identification of barriers may increase understanding of why goals and 
outcomes are not achieved 
• A list of  interventions – these may be implemented to address the barriers and help 
improve the patients experience and outcomes  
• The RDOT - this captures all the relevant information above. 
Further details of the RNG Outcomes Pack is discussed in the article by Gardiner, Harman and 
Alderdice (2015).   
In order to fully assess the functionality of the RDOT, funding was obtained from the BDA to 
undertake a multicentre audit. The primary aim of this multicentre audit was to determine if the 
use of the RDOT could capture changes in parameters used to measure nutritional status and 
biochemical measures in outpatients receiving dietetic intervention in clinical practice. The 
secondary aim was to ascertain the impact of potential barriers and facilitators on the success of 
the patient outcome. 
 
Methods 
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119 renal dietetic units, attached to UK NHS hospitals, were eligible to take part in the audit. 
Recruitment of units was conducted via invitation through emailing BDA-RNG group members via 
a members discussion forum as well as disseminating details at national meetings and in national 
journals.  A letter clarifying the purpose, safety and security of the audit data was made available 
to share with the participating trusts Research and Audit department. No ethical approval was 
required as the audit only required outcome data from routine dietetic practice and did not 
involve collecting demographics or personal data. 
Participating units were provided with the RNG Dietetic Outcomes Pack, the RDOT (on an Excel 
spreadsheet), an audio-visual guide of ‘How to Complete the Tool’ and a Frequently Asked 
Questions’ document. A mentor from the BDA-RNG working group was allocated to each unit to 
provide any support and guidance needed. The audit was conducted from September 2013 to May 
2014. 
Each unit was instructed to collect relevant outcomes data from all eligible outpatients referred in 
the first three months of the audit, inputting data into the RDOT.  Inclusion and exclusion criteria 
were provided (Table 1).  No minimum or maximum numbers of patients were imposed.  
Table 1:  Patient inclusion and exclusion criteria 
Inclusion Criteria  Exclusion criteria 
 
Male and female adult patients (18 years old) with CKD 
stage 4 and 5. 
 
All new outpatient referrals for dietary management of 
serum potassium or phosphate, or oral nutrition 
support 
 
 
Inpatients 
 
Paediatric patients 
 
Patients with functioning kidney transplants 
 
Dietitians were instructed to focus on collecting outcomes data on one dietary intervention at a 
time, i.e. potassium, phosphate or ONS. When the patient was provided with more than one 
dietary intervention, data was collected as individual entries or the main intervention was 
prioritised for data collection.  
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At the start of the episode of care, collection of data included patients’ modality, date of first 
assessment, goals set, barriers at start of episode of care and the overall outcome being measured 
e.g. serum phosphate. A drop down menu provided options for most of the data entry.  
At the end of the episode of care, data was recorded to include date of final review, the outcome 
measured e.g. serum phosphate, number of reviews undertaken and outcome of each goal set 
(categorised as not achieved, progress towards, achieved, and achieved and maintained). The 
outcome of each goal was determined by outcome measures as suggested in the outcome models. 
Barriers at the end of episode of care, use of interventions and the result of the overall clinical 
outcome were also recorded. 
 
The timeframe allowed any number of reviews within a maximum of six months from the initial 
assessment to allow sufficient time for the episode of care to be completed. The length of episode 
of care was automatically calculated in the RDOT. 
A positive outcome was defined as the overall desired outcome being met e.g. “to achieve and 
maintain a serum phosphate within the target range”.    
Upon completion of the audit, all units emailed their completed RDOT to their allocated mentor 
for analysis using secure email. All results were presented as n (%); mean and SD were calculated 
using Excel. Wilcoxon test was used to determine the difference in measurements (serum 
potassium, phosphate, weight) from start to end of episode of care and in relation to number of 
times seen using a statistical program  R core team (2015); where statistical significance was 
agreed at  p<0.05. 
 
Results 
A convenience sample of 27/119 (22%) renal dietetic units agreed to participate in the audit. 78% 
(n=21/27) completed the audit, submitting the completed RDOT at the end of the nine months.  
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Five did not start the audit due to staffing issues and one unit completed the tool incorrectly and 
the data could not be used. Thirty three entries into the RDOT where the final outcome was not 
recorded were removed from the analyses. Complete data was collected on 742 episodes of care 
with 32% (n=235/742) for potassium management, 50% (n=369/742) for phosphate management 
and 18% (n=138/742) for ONS. Table 2 shows the CKD stage and the number of consultations.  
Table 2: Characteristics 
HD= Haemodialysis; PD= Peritoneal dialysis; CM= Conservative management; MD= Missing data 
 
Table 3 summarises the changes in biochemical and nutritional parameters used to measure 
aspects of nutritional status during the audit period. Most patients were seen at least twice by the 
renal dietitian where significant changes were seen in serum potassium and phosphate levels in 
most CKD stages (P=0.01). For those requiring ONS an increase in weight was noted in 
haemodialysis patients when seen after three or more consultations (p=0.01). 
Significant improvements were seen for both the potassium and phosphate models respectively, 
as serum potassium levels improved for 87% (n=205/235) and serum phosphate improved for 66% 
(n=245/369).   More than half of the patients referred for ONS (58%, n=81/138) achieved the 
outcome. Weight was frequently used as a parameter of nutritional status where 50% noted 
weight gain (n=62/124).  In some cases, other parameters were used in addition or instead of 
weight including anthropometry (n=5), BMI (n=14) and SGA (n=5) with all achieving the outcome 
 Potassium Phosphate ONS 
Episodes 
of care 
235 369 138 
Number of 
times seen 
Total 
(n) 
 
1 2 >3 MD Total 
(n) 
 
1 2 >3 MD Total 
(n) 
 
1 2 >3 MD 
CKD Stage 
4 
5 HD 
5PD 
5CM 
MD 
 
 
124 
91 
5 
15 
0 
 
41 
17 
4 
5 
0 
 
42 
47 
1 
4 
0 
 
24 
24 
0 
4 
0 
 
17 
3 
0 
2 
0 
 
80 
245 
24 
19 
1 
 
24 
39 
4 
4 
0 
 
35 
104 
14 
11 
0 
 
 
 
21 
100 
6 
4 
1 
 
 
0 
2 
0 
0 
0 
 
35 
79 
11 
10 
3 
 
14 
2 
0 
1 
0 
 
4 
24 
1 
3 
1 
 
17 
49 
10 
6 
2 
 
0 
4 
0 
0 
0 
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except for albumin where only 38% (n=7/18) achieved the outcome following dietetic 
intervention.  
Table 3: CKD stage and change in outcome measures for all patients 
CKD Stage Episodes of care 
(n) 
Baseline mean (SD) Final mean (SD) P value  
Potassium management (mmol/l) 
CKD Stage 4  108 5.9 (0.33) 5.0 (0.38) <0.01* 
CKD Stage 5 CM 12 5.8 (0.28) 5.0 (0.5) <0.01* 
CKD Stage 5 HD 82 6.2 (0.89) 5.0 (0.61) <0.01* 
CKD Stage 5 PD 4 5.6 (1.7) 4.7 (0.75) 0.2 
Phosphate management (mmol/l) 
CKD Stage 4 50 1.83 (0.30) 1.42 (0.16) <0.01* 
CKD Stage 5 CM 6 1.77 (0.26) 1.49 (0.14) 0.03* 
CKD Stage 5 HD 162 2.03 (0.51) 1.44 (0.22) <0.01* 
CKD Stage 5 PD 17 1.93 (0.31) 1.42 (0.28) <0.01* 
Oral nutrition support (weight in kg) 
CKD Stage 4 17 61.7 (14.95) 60 (14.8) 0.96 
CKD Stage 5 CM 6 68.6 (17.4) 70.4 (16.9) 0.09 
CKD Stage 5 HD 31 65.0  (15.07) 65.9 (14.47) 0.01* 
CKD Stage 5 PD 6 73.2 (18.2) 73.7 (17.4) 0.46 
Oral nutrition support (BMI in kg/m2) 
CKD Stage 4 5 21.7 (4.2) 20.6 (4.3) 1.00 
CKD Stage 5 CM 3 23.7 (3.9) 24.3 (9.5) 1.00 
CKD Stage 5 HD 2 23.5 (3.57) 23.5 (4) N/A 
CKD Stage 5 PD 2 22.6 (2.6) 24.5 (3.2) 1.00 
Statistical test - Wilcoxon test on difference*p<0.05 
 
 
 
 
 
 
 
 
 
 
Table 4: - Goals agreed and whether goal was achieved within the episode of care  
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A= Achieved overall outcome.  B=did not achieve overall outcome 
 
Goal Achieved the goal at end of consultation 
Potassium Phosphate  ONS  
A B A B A B 
Achieve nutritional 
adequacy 
11 2 21 11 32 23 
Improve oral intake   1 2 53 49 
Improved diet related bowel 
function 
  1 0 3 0 
Improved functionality     1 1 
Reduced phosphate related 
symptoms 
1 0 19 11   
Achieve serum potassium 
within target range 
201 30     
Improve bloods glucose 
levels 
6 0 1 0 1 0 
Achieve serum phosphate 
within target range 
2 0 241 124   
Achieve target weight 1 0 2 0 5 2 
Improve BMI 2 1 2 2 11 16 
Improve anthropometry     3 1 
Reduce fat mass   2 2 25 12 
Achieve stable weight 36 6 17 14 28 13 
Understand benefits of 
dietary advice 
130 22 128 68 38 26 
Understand how to make 
dietary changes 
90 11 79 44 13 10 
Achieve agreed dietary 
change 
36 3 30 11 2 2 
Able to make agreed changes 
to diet 
31 3 11 7 3 1 
Improve motivation to make 
changes 
4 0 37 21 2 1 
Improve concordance with 
relevant prescribed products 
60 15 97 49 37 26 
Patient has positive 
experience 
53 4 89 37 9 13 
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Goals 
Goals were agreed at the start of the consultation as shown in table 4. The majority of goals linked 
to biochemistry, nutritional status, motivation and knowledge. For those who did not achieve the 
overall desired outcome (B), 50% (n=181/362) of the patients still demonstrated an improvement 
in knowledge and 50% (n=33/66) in motivation and importance of dietary advice. 
Barriers 
To add context to the data, the dietitian identified barriers present at the start and end of the 
episode of care. The % change in each barrier is shown in table 5 where “no barriers” consistently 
increased by the end of the episode of care for each model.  
Intervention 
The dietitians recorded how they may have overcome some of these barriers using various 
‘interventions’. Where interventions such as ‘provide individualised information in a suitable 
format’ and ‘provide further advice to improve knowledge’ were utilised, a positive impact on 
patients outcomes were observed.  “Non dietetic interventions” were also noted such as patient 
receiving a transplant (n=5/742), starting dialysis (n=36/742), having dialysis dose increased 
(n=10/742) or other medical/surgical procedures (n=9/742), all achieving a positive outcome.  
Where interventions requiring liaising with medical or nursing staff were utilised this negatively 
affected the patient’s outcome. In these cases delays in acquiring medication were identified as a 
barrier. 
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Table 5: % change in the number of barriers identified by the renal dietitian from the beginning 
and end of the episode of care.  
Barrier Change (%) 
Potassium  Phosphate  ONS  
0 No barriers +82 +83 +119 
1  
Behavioural 
Low motivation -48 -34 +17 
Low confidence to change  -100 -81 -75 
Poor adherence with 
medications/supplements 
-16 -85 +33 
Poor attendance  0 +700 0 
2  
Psychological 
Low mood/anxiety -44 -42 -18 
Disordered eating -50 -29 -56 
3  
Practical/social 
Poor/lack of cooking facilities -100 -33 -67 
Impaired ability to shop -41 -46 -50 
Financial difficulties  +100 +100 
Lack of social support +100 -40 -67 
Lifestyle issues -66 -47 0 
4 
physical/symptom 
Anorexia -50 -14 -60 
GI symptoms -38 -31 -64 
Dysphagia  -100 -100 
Fatigue -100 -80 -60 
Pain  -50 -25 
5 
 information 
Unsuitable sources of additional 
information e.g. internet 
-100 -100  
Poor understanding -61 -72 -57 
Literacy/ language barriers 0 -33 0 
Learning difficulties/cognitive 
impairment 
-11 -21 0 
Lack of capacity +100 0  
6  
Organisational  
Problems with meal provisions -86 -100 +100 
Poor/inadequate staffing 0 -6 +12 
Delay in acquiring 
medication/supplements 
 -43 -100 
Delay in starting dialysis -100 +100 -200 
Poor access to clinic/support groups    
7  
Medical 
Co-morbidity – pt has CVD +33 +100 -25 
Co-morbidity – pt has diabetes -21 -13 -75 
Adverse changes in medical 
conditions 
-75 +80 +38 
Inadequate dialysis -72 -44 -400 
Modality change (HD-PD) -50 -67  
Patient not for dialysis -100 -50 0 
Frequent hospital admissions +100 0 -25 
Clinical decision not to prioritise 
dietetic intervention 
 +300 0 
8 
 Pharmacology  
Delay in acquiring 
medication/supplements 
-100 -27 -60 
Medication change adversely 
affecting dietetic outcome 
-71 -33 -75 
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9  
Biochemical 
Hyper/hypocalaemia -100 -62 -100 
PTH above or below RA guidelines  -27  
Low bicarbonate levels -75 -100 -100 
10  
Other 
Other -47 -29 -50 
-= reduction, +=increase 
 
Discussion 
The aim of this multicentre audit was to determine if the use of the RDOT could capture changes 
in parameters used to measure nutritional status and biochemical measures in patients with CKD 
receiving dietetic intervention in clinical practice. 
87% of patients were able to show a clinically significant improvement in their biochemical levels 
for potassium and 66% for phosphate management, whilst under the care of the renal dietitian. 
Improvements in phosphate management have been observed previously with dietetic 
intervention (Sullivan et al. 2009; Reddy et al. 2009; Caldeira et al. 2011; Karavetian and Ghaddar 
2013). For the ONS model, just over half of the patients were able to show a small increase in body 
weight though this change was not significant except in haemodialysis patients. This may have 
been due to several factors including: weight maintenance being a more appropriate goal than 
weight gain; an insufficient length of time for follow up to see a clinically significant change (mean 
length of episode of care for ONS was 101 days); weight being affected by fluid status or the 
presence of several non-modifiable barriers e.g. frequent hospital admissions (which were 
frequently found in this patient group). Albumin was also used as a measure of nutritional status 
in this audit, however the reliability of this parameter is questioned due to the influence of non-
nutritional factors (Friedman and Fadem, 2010) 
 
The RDOT not only captured the outcome of the patients during the audit period but provided 
context to the results recorded. Goals agreed with the patient at the start of the episode of care 
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demonstrated the steps used to help achieve overall outcome e.g. increase knowledge or reduce 
symptoms. This was particularly beneficial in instances where the outcome was not achieved e.g. 
phosphate may not be in target range at the end of dietetic intervention but individual goals may 
have been achieved such as reduce phosphate related symptoms, understand benefits of dietary 
advice or where the outcome may not have been solely influenced by dietetic care e.g. when a 
patient receives improvement in dialysis treatment. 
Healthcare professionals can make assumptions regarding their impact without appreciating the 
context of external influences in clinical practice. Recording the presence of a barrier appeared to 
predispose whether patients achieved their outcome for all three outcome models.  Therefore it 
would appear essential to record these at the start of any dietetic intervention and implement 
strategies to overcome them. In fact, the results illustrated that through dietetic intervention, 
many patients were able to reduce their number of modifiable barriers. 
Some interventions influenced the achievement of outcomes. Yet it was of particular interest that 
patients were less likely to achieve their outcome for phosphate management if the intervention 
‘Identify problems and liaise with medical/nursing staff’ was reported. Whilst it cannot be certain 
what problems were identified in each case, it is quite likely that issues around binder prescription 
were amongst these.  This is further supported by the identified barrier ‘delays in acquiring 
medication’ being an additional barrier to achieving outcome in phosphate management. 
Therefore the recent legislation change which allows dietitians to supplementary prescribe is most 
welcomed. In some units, the use of established local protocols and patient group directions may 
at least go some way to overcome this issue. 
 
One limitation of this audit is that it has relied on the accuracy of the individual dietitians when 
completing the RDOT. To minimise this effect an audio visual guide, a Frequently Asked Questions’ 
document and a mentor from the Working Group was provided. Despite this, Inter-person 
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variability will undoubtedly have taken place, as often patients are seen by more than one renal 
dietitian within any unit. It was also noted that some of the entries were incomplete indicating 
that the practice of collecting outcomes is still not embedded in clinical practice. An evaluation 
questionnaire was used to obtain feedback from the participants. The results were collated as 
seen via this link 
https://www.bda.uk.com/regionsgroups/groups/renal/evaluation_of_outcomes_tool. 
In order to overcome some of these limitations in future use, a ‘How to Guide’ has been 
developed for use alongside the RDOT and is available on the Think Kidneys website. 
 
This multi centre audit has shown that renal dietetic interventions are effective for patients with 
late stages of CKD. The RDOT provides the ability to visualise changes in clinical parameters whilst 
capturing important data relating to a patients’ outcome. This is vital to renal dietitians and 
commissioners of services in the current NHS climate. And whilst this is only a starting point for 
collecting data it has been used to influence other specialist dietetic groups regarding capturing 
outcomes in practice – particularly detailing barriers which may limit outcomes. This will help to 
shape services, question historic practice and aid health care professionals to prove their worth. 
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Key Points 
1. Providing both cost effective and clinically effective services is essential in today’s NHS.  
However, it can be difficult to capture this data in day to day practice. 
2. The identification and development of outcome measures for dietetics has been an on-
going challenge for the profession.  
3. This article describes how the Renal Nutrition Group of the British Dietetic Association 
developed three renal-specific Dietetic Outcome Models and a Renal Dietetic Outcome 
Tool (RDOT) to measure dietetic outcomes in potassium and phosphate management and 
oral nutrition support in patients with Chronic Kidney Disease (CKD) for use in daily clinical 
practice. 
4. The results from the audit showed that renal dietetic interventions are effective for patients 
with late stages of CKD.  
5. The outcomes tool was found to be a useful addition to clinical practice as it records 
changes in clinical parameters whilst capturing details of the dietetic intervention and other 
relevant factors, including barriers.  
6. The tool could be modified to incorporate other dietetic models (such as fluid management 
or weight management), goals, barriers and dietetic interventions for other specialist areas. 
These aspects are vital to dietitians and commissioners of services in the current NHS 
climate.  
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Reflective Questions 
1. What are the main challenges in demonstrating that dietitians are both cost and clinically effective in 
todays NHS? 
2. What are the limitations in the current research into the effectiveness of Renal dietitians? 
3. What were the primary and secondary aims of this audit? Did it meet its aims? 
4. Which dietetic intervention was found to be the most effective – and which the least? 
Why do you think this was? 
5. What findings were of specific interest to Renal dietitians and what do you think can be generalisable 
to other clinical areas within Dietetics? 
 
 
